Inhibition of VTA Neurons Activates the Centrally Projecting Edinger-Westphal Nucleus: Evidence of a Stress-reward Link?

Overview

Journal J Chem Neuroanat

Specialties Anatomy & Histology
Chemistry
Neurology

Date 2013 Jun 25

PMID 23792226

Citations 8

Authors

Andrey E Ryabinin

Davelle L Cocking

Simranjit Kaur

Affiliations

Soon will be listed here.

Abstract

The primary site of urocortin 1 (Ucn1) expression in the brain is the centrally projecting Edinger-Westphal nucleus. The EWcp is innervated by dopaminergic neurons of the ventral tegmental area (VTA). To investigate whether activity of EWcp is regulated by the VTA, we investigated the effects of local pharmacological inhibition of VTA activity on the induction of Fos immunoreactivity in the EWcp of male C57BL/6J mice. A unilateral intracranial administration of the GABA agonist muscimol aimed at the VTA resulted in increased number of Fos-positive cells in the EWcp. This induction was lower than that produced by an intraperitoneal injection of 2.5 g/kg of ethanol. To investigate whether inhibition of dopaminergic neurons was responsible for induction of Fos, a second experiment was performed where the dopamine agonist quinpirole was unilaterally injected targeting the VTA. Injections of quinpirole also significantly induced Fos in the EWcp neurons. The induction occurred only on the side of the EWcp ipsilateral to the VTA injection. These results indicate that activity of EWcp is inhibited by tonic activity of dopaminergic VTA neurons, and that unilateral projections of VTA onto Ucn1-containing EWcp neurons provide a link between systems regulating approach and avoidance behaviors.

Citing Articles

Neuromedin U Neurons in the Edinger-Westphal Nucleus Respond to Alcohol Without Interfering with the Urocortin 1 Response.

Medrano M, Allaoui W, Haddad R, Makrini-Maleville L, Valjent E, Smolders I Neurochem Res. 2024; 49(12):3277-3296.

PMID: 39266897 PMC: 11502588. DOI: 10.1007/s11064-024-04238-1.

Peptidergic and functional delineation of the Edinger-Westphal nucleus.

Priest M, Freda S, Rieth I, Badong D, Dumrongprechachan V, Kozorovitskiy Y Cell Rep. 2023; 42(8):112992.

PMID: 37594894 PMC: 10512657. DOI: 10.1016/j.celrep.2023.112992.

Animal studies reveal that the ghrelin pathway regulates alcohol-mediated responses.

Jerlhag E Front Psychiatry. 2023; 14:1050973.

PMID: 36970276 PMC: 10030715. DOI: 10.3389/fpsyt.2023.1050973.

Edinger-Westphal peptidergic neurons enable maternal preparatory nesting.

Topilko T, Diaz S, Pacheco C, Verny F, Rousseau C, Kirst C Neuron. 2022; 110(8):1385-1399.e8.

PMID: 35123655 PMC: 9090132. DOI: 10.1016/j.neuron.2022.01.012.

Gray areas: Neuropeptide circuits linking the Edinger-Westphal and Dorsal Raphe nuclei in addiction.

Pomrenze M, Walker L, Giardino W Neuropharmacology. 2021; 198:108769.

PMID: 34481834 PMC: 8484048. DOI: 10.1016/j.neuropharm.2021.108769.

References

Kozicz T, Bittencourt J, May P, Reiner A, Gamlin P, Palkovits M . The Edinger-Westphal nucleus: a historical, structural, and functional perspective on a dichotomous terminology. J Comp Neurol. 2011; 519(8):1413-34. PMC: 3675228. DOI: 10.1002/cne.22580. View

Neufeld-Cohen A, Tsoory M, Evans A, Getselter D, Gil S, Lowry C . A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery. Proc Natl Acad Sci U S A. 2010; 107(44):19020-5. PMC: 2973872. DOI: 10.1073/pnas.1013761107. View

Gaszner B, Korosi A, Palkovits M, Roubos E, Kozicz T . Neuropeptide Y activates urocortin 1 neurons in the nonpreganglionic Edinger-Westphal nucleus. J Comp Neurol. 2006; 500(4):708-19. DOI: 10.1002/cne.21177. View

Gaszner B, Csernus V, Kozicz T . Urocortinergic neurons respond in a differentiated manner to various acute stressors in the Edinger-Westphal nucleus in the rat. J Comp Neurol. 2004; 480(2):170-9. DOI: 10.1002/cne.20343. View

Grace A . The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction. 2000; 95 Suppl 2:S119-28. DOI: 10.1080/09652140050111690. View

Lewis K, Li C, PERRIN M, Blount A, Kunitake K, Donaldson C . Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A. 2001; 98(13):7570-5. PMC: 34709. DOI: 10.1073/pnas.121165198. View

Weitemier A, Ryabinin A . Lesions of the Edinger-Westphal nucleus alter food and water consumption. Behav Neurosci. 2005; 119(5):1235-43. DOI: 10.1037/0735-7044.119.5.1235. View

Turek V, Ryabinin A . Expression of c-Fos in the mouse Edinger-Westphal nucleus following ethanol administration is not secondary to hypothermia or stress. Brain Res. 2005; 1063(2):132-9. DOI: 10.1016/j.brainres.2005.09.056. View

Reyes T, Lewis K, PERRIN M, Kunitake K, Vaughan J, Arias C . Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci U S A. 2001; 98(5):2843-8. PMC: 30227. DOI: 10.1073/pnas.051626398. View

10.

Gong S, Zheng C, Doughty M, Losos K, Didkovsky N, Schambra U . A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature. 2003; 425(6961):917-25. DOI: 10.1038/nature02033. View

11.

Rodaros D, Caruana D, Amir S, Stewart J . Corticotropin-releasing factor projections from limbic forebrain and paraventricular nucleus of the hypothalamus to the region of the ventral tegmental area. Neuroscience. 2007; 150(1):8-13. DOI: 10.1016/j.neuroscience.2007.09.043. View

12.

Jeziorski M, White F . Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors. Synapse. 1989; 4(4):267-80. DOI: 10.1002/syn.890040403. View

13.

Congar P, Bergevin A, Trudeau L . D2 receptors inhibit the secretory process downstream from calcium influx in dopaminergic neurons: implication of K+ channels. J Neurophysiol. 2002; 87(2):1046-56. DOI: 10.1152/jn.00459.2001. View

14.

Kalivas P, Duffy P, Latimer L . Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. J Pharmacol Exp Ther. 1987; 242(3):757-63. View

15.

Linden A, Greene S, Bergeron M, Schoepp D . Anxiolytic activity of the MGLU2/3 receptor agonist LY354740 on the elevated plus maze is associated with the suppression of stress-induced c-Fos in the hippocampus and increases in c-Fos induction in several other stress-sensitive brain regions. Neuropsychopharmacology. 2003; 29(3):502-13. DOI: 10.1038/sj.npp.1300321. View

16.

Kozicz T, Yanaihara H, Arimura A . Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J Comp Neurol. 1998; 391(1):1-10. DOI: 10.1002/(sici)1096-9861(19980202)391:1<1::aid-cne1>3.0.co;2-6. View

17.

Weitemier A, Tsivkovskaia N, Ryabinin A . Urocortin 1 distribution in mouse brain is strain-dependent. Neuroscience. 2005; 132(3):729-40. DOI: 10.1016/j.neuroscience.2004.12.047. View

18.

Kaur S, Ryabinin A . Ghrelin receptor antagonism decreases alcohol consumption and activation of perioculomotor urocortin-containing neurons. Alcohol Clin Exp Res. 2010; 34(9):1525-34. PMC: 2929279. DOI: 10.1111/j.1530-0277.2010.01237.x. View

19.

Ryabinin A, Galvan-Rosas A, Bachtell R, Risinger F . High alcohol/sucrose consumption during dark circadian phase in C57BL/6J mice: involvement of hippocampus, lateral septum and urocortin-positive cells of the Edinger-Westphal nucleus. Psychopharmacology (Berl). 2002; 165(3):296-305. DOI: 10.1007/s00213-002-1284-y. View

20.

Bachtell R, Weitemier A, Galvan-Rosas A, Tsivkovskaia N, Risinger F, Phillips T . The Edinger-Westphal-lateral septum urocortin pathway and its relationship to alcohol consumption. J Neurosci. 2003; 23(6):2477-87. PMC: 6742045. View